We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

29 hedge funds and large institutions have $16.1M invested in ALPS Medical Breakthroughs ETF in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

172% more capital inflows, than outflows

Capital inflows: $12.3M | Capital outflows: $4.54M

61% more funds holding

Funds holding: 18 → 29 (+11)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $589K

Holders
29
Holders Change
+11
Holders Change %
+61.11%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
10
Reduced
3
Closed
4
Calls
–
Puts
$589​K
Net Calls
-⁠$589​K
Net Calls Change
-⁠$589​K

SBIO Hedge Fund Activity: Q3 2015 in Review

29 of the 3,589 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2015, worth a combined $16.1M — up 25% from $12.8M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new SBIO positions and 4 closed out — a net gain of 10 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $3.18M. The largest seller was LPL Financial, cutting an estimated $2.18M.

  • 29 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2015, up from 18 in Q2 2015.
  • Funds reported $16.1M of ALPS Medical Breakthroughs ETF stock for Q3 2015, up 25% quarter-over-quarter.
  • 14 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2015 and 4 closed out, a net change of +10 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q3 2015 was Citadel Advisors, an estimated $3.18M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q3 2015 was LPL Financial, an estimated $2.18M sold.

Based on aggregated 13F filings for Q3 2015.